Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer
Shengting Wang, Yufang Wang, Qian Li, et al.
Redox Biology (2023) Vol. 67, pp. 102896-102896
Open Access | Times Cited: 21

Showing 21 citing articles:

CircRNA and lncRNA-encoded peptide in diseases, an update review
Qian Yi, Jianguo Feng, Weiwu Lan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
LACTB suppresses liver cancer progression through regulation of ferroptosis
Kaixuan Zeng, Na Huang, Nanbin Liu, et al.
Redox Biology (2024) Vol. 75, pp. 103270-103270
Open Access | Times Cited: 6
Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing
Ji Zhang, Xinyu Xu, Hong‐Wei Deng, et al.
Pharmacology & Therapeutics (2024) Vol. 261, pp. 108697-108697
Closed Access | Times Cited: 4
Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination
Weimin Xu, Zhebin Hua, W. Yaosheng, et al.
Advanced Science (2025)
Open Access
Role of circular RNAs in cancer therapy resistance
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Lixin Li, Y. Hao, Lei Dong, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Small open reading frame-encoded microproteins in cancer: identification, biological functions and clinical significance
Tingting Zhang, Zhang Li, Jiao Li, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
CircRNA encoded-peptide: Potential stock in the transcriptomics market
Siyuan Ma, Sensen Su, Xiuna Zhang, et al.
Life Sciences (2025), pp. 123643-123643
Closed Access
Novel Truncated Peptide Derived From circCDYL Exacerbates Cardiac Hypertrophy
Mengyang Li, Wei Ding, Xinyu Fang, et al.
Circulation Research (2025)
Closed Access
HER2 and Epigenetic Modifications in Tumorigenesis: Mechanisms and Therapeutic Implications
Zhoujie Ye, Hyeong Gon Yu, Liping Zhu, et al.
IntechOpen eBooks (2025)
Closed Access
Circular RNAs in Breast Cancer: An Update
Haolin Bao, Jiehan Li, Qihang Zhao, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 158-158
Open Access | Times Cited: 2
Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification
Shengting Wang, Qian Li, Yufang Wang, et al.
Journal of Applied Genetics (2024) Vol. 65, Iss. 4, pp. 797-807
Closed Access | Times Cited: 2
The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications
Hongkun Hu, Jinxin Tang, Hua Wang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Translation of circular RNAs
Giorgi Margvelani, Karol Andrea Arizaca Maquera, Justin R. Welden, et al.
Nucleic Acids Research (2024)
Open Access | Times Cited: 2
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 1
A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship
Jing Zeng, Zheng Chen, Yuxin He, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116821-116821
Closed Access | Times Cited: 1
Resistance mechanisms and prospects of trastuzumab
Lizhe Wang, Yu Wang, Y Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Translation of Circular RNAs
Giorgi Margvelani, Karol Andrea Arizaca Maquera, Justin R. Welden, et al.
(2024)
Open Access
First report on exploration of structural features of natural compounds (NPACT database) for anti-breast cancer activity (MCF-7): QSAR-based virtual screening, molecular docking, ADMET, MD simulation, and DFT studies
Lomash Banjare, Anjali Murmu, Nilesh Kumar Pandey, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access
cDTL contributes to breast cancer progression through regulating redox homeostasis via affecting the function of system Xc-
Shengting Wang, Libing Liu, Xiaoming Li, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 744, pp. 151196-151196
Closed Access
Page 1

Scroll to top